MediPal Holdings Corporation (TYO:7459)

Market Cap	543.27B +7.1%
Revenue (ttm)	3.82T +4.0%
Net Income	42.53B +5.6%
EPS	206.67 +7.0%
Shares Out	204.70M
PE Ratio	12.84
Forward PE	13.36
Dividend	64.00 (2.40%)
Ex-Dividend Date	Mar 30, 2026

Volume	13,500
Open	2,636.00
Previous Close	2,654.00
Day's Range	2,620.50 - 2,671.00
52-Week Range	2,249.00 - 3,070.00
Beta	-0.02
Analysts	Hold
Price Target	2,912.50 (+9.53%)
Earnings Date	May 14, 2026

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,061
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7459

Financial Performance

In fiscal year 2026, MediPal Holdings's revenue was 3.82 trillion, an increase of 3.98% compared to the previous year's 3.67 trillion. Earnings were 42.53 billion, an increase of 5.60%.